Todd C Brady Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Todd C Brady.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Todd C Brady. Todd C Brady is a President and CEO in Aldeyra Therapeutics, Inc. ($ALDX) and a Director in Evoke Pharma Inc ($EVOK) and a Director in Spring Bank Pharmaceuticals, Inc. ($SBPH) and a in Oncobiologics, Inc. ($ONS) and a Director in Oncobiologics, Inc. ($ONS).
Address: C/O EVOKE PHARMA, INC. 12555 HIGH BLUFF DRIVE, SUITE 385 SAN DIEGO 92130 CA
Companies in which Todd C Brady is an Insider
Aldeyra Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Todd C Brady: President and CEO
Holdings: 948,835 shares
Current Value: $4,744,175
Latest Transaction: Apr 14 2021
$ALDX Market Capitalization: $30.29M
$ALDX Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Evoke Pharma Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Todd C Brady: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 29 2020
$EVOK Market Capitalization: $32.36M
$EVOK Previous Close: $2.64
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
F-star Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Todd C Brady: Director
Holdings: 60,016 shares
Current Value: $450,120
Latest Transaction: Oct 01 2020
$SBPH Market Capitalization: $58.25M
$SBPH Previous Close: $7.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Outlook Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Todd C Brady: Director
Holdings: 28,985 shares
Current Value: $96,810
Latest Transaction: Oct 30 2017
$OTLKW Market Capitalization: $76.86M
$OTLKW Previous Close: $3.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Todd C Brady
Sentiment: All, ALDX, EVOK, SBPH, OTLKW
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14 2021 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Option Exercise | A | 11.71 | 250,000 | 2,927,500 | 250,000 | |
| Apr 14 2021 | ALDX | Aldeyra Therapeuti ... | Brady Todd C | President and CEO | Grant | A | 0.00 | 46,619 | 0 | 948,835 | 902.2 K to 948.8 K (+5.17 %) |
| Oct 01 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 9,235 | 0 | 60,016 | 50.8 K to 60 K (+18.19 %) |
| Jul 01 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 8,418 | 0 | 50,781 | 42.4 K to 50.8 K (+19.87 %) |
| Jun 25 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Option Exercise | A | 1.60 | 7,500 | 12,000 | 7,500 | |
| May 29 2020 | EVOK | Evoke Pharma Inc | Brady Todd C | Director | Option Exercise | A | 2.60 | 57,750 | 150,150 | 57,750 | |
| Apr 01 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 13,306 | 0 | 42,363 | 29.1 K to 42.4 K (+45.79 %) |